Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2729.25 | 653 / 653 | 100% | 55.88 | 602 / 605 |
breast | 100% | 3966.15 | 459 / 459 | 98% | 27.77 | 1092 / 1118 |
lung | 100% | 2295.61 | 577 / 578 | 97% | 33.55 | 1118 / 1155 |
skin | 99% | 2241.90 | 1787 / 1809 | 94% | 39.70 | 445 / 472 |
kidney | 97% | 1343.49 | 86 / 89 | 96% | 35.69 | 865 / 901 |
bladder | 100% | 2017.81 | 21 / 21 | 88% | 25.04 | 445 / 504 |
esophagus | 100% | 2085.83 | 1444 / 1445 | 88% | 23.28 | 161 / 183 |
uterus | 100% | 2571.51 | 170 / 170 | 84% | 20.84 | 386 / 459 |
prostate | 96% | 1156.90 | 235 / 245 | 77% | 10.17 | 388 / 502 |
ovary | 99% | 1380.64 | 178 / 180 | 62% | 8.66 | 265 / 430 |
adrenal gland | 100% | 3569.53 | 258 / 258 | 58% | 8.73 | 133 / 230 |
intestine | 99% | 1972.99 | 958 / 966 | 55% | 9.65 | 292 / 527 |
stomach | 78% | 869.76 | 280 / 359 | 70% | 12.33 | 201 / 286 |
liver | 91% | 872.21 | 206 / 226 | 56% | 10.87 | 229 / 406 |
pancreas | 49% | 333.23 | 160 / 328 | 93% | 28.35 | 166 / 178 |
brain | 46% | 345.16 | 1211 / 2642 | 68% | 13.73 | 479 / 705 |
adipose | 100% | 5249.60 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 75.03 | 29 / 29 |
spleen | 100% | 3186.86 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.71 | 1 / 1 |
blood vessel | 100% | 1824.78 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 1438.97 | 838 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 24.86 | 43 / 45 |
muscle | 74% | 875.86 | 594 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 66% | 2581.53 | 614 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 45% | 5.40 | 36 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050434 | Biological process | positive regulation of viral transcription |
GO_0042308 | Biological process | negative regulation of protein import into nucleus |
GO_0046328 | Biological process | regulation of JNK cascade |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030111 | Biological process | regulation of Wnt signaling pathway |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005730 | Cellular component | nucleolus |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0030957 | Molecular function | Tat protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0030332 | Molecular function | cyclin binding |
Gene name | MDFIC |
Protein name | MyoD family inhibitor domain containing MyoD family inhibitor domain-containing protein (I-mfa domain-containing protein) (hIC) |
Synonyms | |
Description | FUNCTION: Required to control the activity of various transcription factors through their sequestration in the cytoplasm. Retains nuclear Zic proteins ZIC1, ZIC2 and ZIC3 in the cytoplasm and inhibits their transcriptional activation (By similarity). Modulates the expression from both cellular and viral promoters. Down-regulates Tat-dependent transcription of the human immunodeficiency virus type 1 (HIV-1) LTR by interacting with HIV-1 Tat and Rev and impairing their nuclear import, probably by rendering the NLS domains inaccessible to importin-beta . Also stimulates activation of human T-cell leukemia virus type I (HTLV-I) LTR . Binds to the axin complex, resulting in an increase in the level of free beta-catenin . Affects axin regulation of the WNT and JNK signaling pathways . Has a role in the development of lymphatic vessel valves. It is required to promote lymphatic endothelial cell migration, in a process that involves down-regulation of integrin beta 1 activation and control of cell adhesion to the extracellular matrix (By similarity). . |
Accessions | ENST00000393486.6 [Q9P1T7-2] ENST00000427207.5 ENST00000431629.5 H7BZY3 C9J104 ENST00000498196.1 ENST00000423503.1 C9J784 H7C4B9 ENST00000448022.1 Q9P1T7 |